aTyr Pharma Inc (NASDAQ:LIFE)

8.74
Delayed Data
As of Oct 15
 0.00 / 0.00%
Today’s Change
2.93
Today|||52-Week Range
13.10
+125.26%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 20.00, with a high estimate of 22.00 and a low estimate of 18.00. The median estimate represents a +128.83% increase from the last price of 8.74.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in aTyr Pharma Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.59
Sales
$266.7K
Reporting Date
Nov 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.37%
 
 
 
 
 
 
Growthannually -21.87%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually -79.23%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.